Stimulus-Responsive Drug Delivery Nanoplatforms for Inflammatory Bowel Disease Therapy

The authors provide an overview of the pathophysiological mechanisms underlying IBD and summarize recent advancements in microenvironmental stimulus-responsive nanocarriers for IBD therapy.